跳至主要内容
临床试验/NCT06885073
NCT06885073招募中不适用

Non-invasive Central Venous Pressure Estimation in Pediatric Patients

Compremium AG2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年3月10日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
Compremium AG
入组人数
100
试验地点
2
主要终点
Safety of external jugular venous occlusion pressure measured non-invasively with CPMX2 to estimate CVP in pediatric patients.

研究概览

简要总结

Central Venous Pressure (CVP) is a standard parameter for hemodynamic monitoring and is currently measured through the insertion of a catheter. The pediatric population is especially vulnerable to risks associated to this invasive procedure, including infection, thrombosis, and pneumothorax. The proposed pilot study will evaluate safety and preliminary efficacy of a new non-invasive ultrasound-based venous occlusion pressure (VOP) monitoring device (CPMX2) in children equipped with an invasive catheter for CVP monitoring as part of standard of care.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

盲法说明

The investigator performing the measurement with CPMX2 is blinded to the invasive CVP measurement until the assessment is complete.

入排标准

年龄范围
— 至 21 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Provision of signed and dated informed consent form
  • Male or female
  • Age: birth to 21 years of age
  • Equipped with a central venous catheter (CVC) for central venous pressure (CVP) monitoring indication as part of standard of care, or undergoing cardiac catheterization.

排除标准

  • Weight less than 2.5kg at the time of enrollment.
  • Bilateral external jugular veins not accessible due to vascular access or dressing.
  • Bilateral skin lesion contraindicating neck Ultrasound
  • Active bleeding
  • Clinically unstable, per clinical assessment by attending physician and/or surgeon

结局指标

主要结局

Safety of external jugular venous occlusion pressure measured non-invasively with CPMX2 to estimate CVP in pediatric patients.

时间窗: Up to 4 days

Safety: Safety of the device shall be evaluated by systematically reporting DDs, ADEs and SADEs and by monitoring the frequency and incidence of these events. The practitioner will be asked to identify any new risks arising during the measurements using the investigational device.

次要结局

未报告次要终点

研究者

发起方
Compremium AG
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验